Noninvasive glucose sensing methods and systems

• US 9,167,993 B2
• Filed: 03/09/2012
• Issued: 10/27/2015
• Est. Priority Date: 01/20/2006
• Status: Active Grant

• Current Assignee: Donald S. Prough, Rinat O. Esenaliev
• Original Assignee: Donald S. Prough, Rinat O. Esenaliev
• Inventors: Esenaliev, Rinat O., Prough, Donald S.
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US13/416,963
• Publication Number:
  US 20120172686A1
• Time in Patent Office: 1,327 Days
• Field of Search: 600/316, 600/365, 600/438
• US Class Current: 1/1
• CPC Class Codes: A61B 5/0095 by applying light and detecting acoustic waves, i.e. photoacoustic measurements
• CPC Class Codes: A61B 5/1075 for measuring dimensions by non-invasive methods, e.g. for determining thickness of tissue layer A61B8/0858 takes precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement

Abstract

New methods and systems for noninvasive glucose monitoring and sensing with electromagnetic waves or ultrasound are disclosed. The methods are based on absolute or relative measurement of tissue dimensions (or changes in the dimensions) including, but not limited to: thickness, length, width, diameter, curvature, roughness as well as time of flight of ultrasound and optical pulses and optical thickness, which change with changing blood glucose concentrations. By measuring noninvasively absolute or relative changes in at least one dimension of at least one tissue or tissue layer or absolute or relative changes in time of flight of ultrasound or optical pulses, one can monitor blood glucose concentration noninvasively.

Claims

1. A method for noninvasive glucose sensing comprising the steps of:

generating ultrasound pulses or waves using an ultrasound transducer,

directing the ultrasound pulses or waves into a target tissue,

detecting reflected, refracted, scattered, back-scattered, or forward-scattered ultrasound pulses or waves from or by boundaries or interfaces in the target tissue using the ultrasound transducer,

measuring;

(1) at least one ultrasound time of flight from the detected ultrasound pulses or waves evidencing the boundaries or interfaces within the target tissue using a processor,

and/or

(2) at least one ultrasound dimension of a specific tissue layer within the target tissue including thickness, length, width, diameter, curvature, or roughness from the detected ultrasound pulses or waves using the processor; and

determining a glucose concentration value from;

(1) the at least one ultrasound time of flight in accordance with an ultrasound time of flight versus glucose calibration curve,

and/or

(2) the at least one ultrasound dimension in accordance with an ultrasound dimension versus glucose calibration curve.

2. The method of claim 1, wherein:

the measuring step comprises measuring;

(1) at least one ultrasound time of flight from the detected ultrasound pulses or waves evidencing the boundaries or interfaces within the target tissue using a processor,

and

(2) at least one ultrasound dimension of the specific tissue layer within the target tissue from the detected ultrasound pulses or waves using the processor, where the ultrasound dimension includes thickness, length, width, diameter, curvature, or roughness, and

the determining step comprises determining a glucose concentration value from;

(1) the at least one ultrasound time of flight in accordance with the ultrasound time of flight versus glucose calibration curve,

and

(2) the at least one ultrasound dimension in accordance with the ultrasound dimension versus glucose calibration curve.

3. The method of claim 1, further comprising the step of:

generating electromagnetic pulses or waves using a laser light source,

directing the electromagnetic pulses or waves into a target tissue,

detecting reflected, refracted, scattered, back-scattered, or forward-scattered electromagnetic pulses or waves from or by the boundaries or interfaces in target tissue using a photodetector,

measuring;

(1) at least one electromagnetic time of flight from the detected electromagnetic pulses or waves evidencing the boundaries or interfaces within the target tissue using the processing unit;

and/or

(2) at least one electromagnetic dimension the specific tissue layer within the target tissue from the detected electromagnetic pulses or waves using a photodetector, and

improving the determining of the glucose concentration value from;

(1) the at least one electromagnetic time of flight in accordance with an electromagnetic time of flight calibration curve,

and/or

(2) the at least one electromagnetic dimension in accordance with an electromagnetic dimension calibration curve,

where the electromagnetic pulses or waves comprises electromagnetic radiation selected from the group consisting of near infrared, infrared, far infrared, visible, or UV light in the wavelength range from about 200 nanometers to about 100 microns;

terahertz waves;

microwaves;

radiowaves;

low-frequency waves;

static electric or magnetic fields;

or combination of different electromagnetic frequencies.

4. The method of claim 3, wherein

the second measuring step comprises measuring:

(1) the at least one electromagnetic time of flight from the detected electromagnetic pulses or waves evidencing the boundaries or interfaces within the target tissue using the processing unit,

and

(2) the at least one electromagnetic dimension of the specific tissue layer within the target tissue from the detected electromagnetic pulses or waves using the processing unit, and

improving the determining of the glucose concentration value from;

(1) the at least one electromagnetic time of flight in accordance with the electromagnetic time of flight calibration curve,

and

(2) the at least one electromagnetic dimension in accordance with the electromagnetic dimension calibration curve.

5. The method of claim 3, wherein the electromagnetic pulses are ultrashort in the range from about 1 femtosecond to about 1 microsecond to provide accurate time of flight or dimension measurement.

6. The method of claim 1, further comprising the steps of:

irradiating the target tissue with short optical pulses or waves to generate thermoelastic ultrasound pulses or waves using a laser light source;

detecting reflected, refracted, scattered, back-scattered, or forward-scattered thermoelastic ultrasound pulses or waves from or by using the ultrasound transducer,

measuring;

(1) at least one time of flight from the detected thermoelastic ultrasound pulses or waves evidencing the boundaries or interfaces within the target tissue using the processing unit,

and/or

(2) at least one dimension of the specific tissue layer within the target tissue from the detected thermoelastic ultrasound pulses or waves using the processing unit; and

improving the determining of the glucose concentration value from;

(1) the at least one thermoelastic ultrasound time of flight in accordance with the ultrasound time of flight versus glucose calibration curve,

and/or

(2) the at least one thermoelastic ultrasound dimension in accordance with the ultrasound dimension versus glucose calibration curve.

7. The method of claim 1, further comprising:

measuring an attenuation, a phase, and a frequency spectrum of the detected ultrasound pulses or waves to improve an accuracy and specificity of the glucose concentration value.

8. The method of claim 1, wherein the target tissue comprises a skin tissue, an eye tissue, a mucosal tissue, a nail bed, a lunula, a connective tissue, a muscle tissue, a blood vessel, a cartilage tissue, or a tendon tissue.

9. The method of claim 8, wherein the skin tissue includes a dermis, an epidermis, or subcutaneous fat and the eye tissue includes a lens, an anterior chamber, a vitreous cavity, an eye ball, or a sclera.

10. The method of claim 1, wherein the ultrasound pulses or waves are detected using reflection, focused reflection, refraction, scattering, polarization, confocal, interferometric, low-coherence, or low-coherence interferometry techniques.

11. The method of claim 1, wherein the ultrasound is in the frequency range from about 20 kHz to about 10 Gigahertz with one, two, or multiple frequencies or broad-band ultrasound generated by a piezoelectric element, or by short electromagnetic pulses irradiating a strongly absorbing medium.

12. A system comprising:

an ultrasound source comprising a pulser/receiver and an ultrasound transducer that generates ultrasound pules or waves and directs the ultrasound pulses or waves into a target tissue,

an ultrasound detection subsystem comprising the ultrasound transducer that detects reflected, refracted, scattered, back-scattered, or forward-scattered ultrasound pulses or waves from or by boundaries or interfaces in the target tissue, and

an electronic subsystem comprising a processing unit that;

(1) records and processes the detected ultrasound pulses or waves to determine;

(a) an ultrasound time of flight from the detected ultrasound pulses or waves evidencing the boundaries or interfaces within the target tissue, and/or

(b) at least one ultrasound dimension of a specific tissue layer within the target tissue from the detected ultrasound pulses or waves, and

(2) calculates;

(a) a glucose concentration value from the at least one ultrasound time of flight in accordance with an ultrasound time of flight versus glucose calibration curve, and/or

(b) a glucose concentration value from the at least one ultrasound dimension in accordance with an ultrasound dimension versus glucose calibration curve.

13. The system of claim 12, further comprising:

a display subsystem comprising a display that displays the determined glucose concentration value in electrical communication with the electronic subsystem, where the electrical communication is wireless or non-wireless.

14. The system of claim 12, further comprising:

an electromagnetic source comprising a pulsed laser light source that generates electromagnetic pulses or waves comprising electromagnetic radiation selected from the group consisting of near infrared, infrared, far infrared, visible, or UV light in the wavelength range from about 200 nanometers to about 100 microns;

terahertz waves;

microwaves;

radiowaves;

low-frequency waves;

static electric or magnetic fields;

or combination of different electromagnetic waves,

an electromagnetic delivery subsystem comprising at least one lens that delivers the electromagnetic pulses or waves to the target tissue,

an electromagnetic detection subsystem comprising a photodetector that detects reflected, refracted, scattered, back-scattered, or forward-scattered electromagnetic pulses or waves from, by, or through the target tissue, and

where the electronic subsystem records and processes the detected electromagnetic pulses or waves to determine at least one electromagnetic time of flight and/or at least one electromagnetic dimension from the detected electromagnetic pulses or waves, and improves the calculation of the glucose concentration value from the at least one electromagnetic time of flight or from at least one electromagnetic dimension.

15. The system of claim 14, further comprising:

a display subsystem comprising a display that displays the determined glucose concentration value in electrical communication with the electronic subsystem, where the electrical communication is wireless or non-wireless.

16. The system of claim 14, wherein the electronic subsystem is configured to record and process a combination of ultrasound pulses or waves;

a combination of electromagnetic pulses or waves;

a combination of ultrasound pulses or waves and electromagnetic pulses or waves;

a combination of generated ultrasound pulses or waves and induced ultrasound pulses or waves;

a combination of electromagnetic pulses or waves and induced ultrasound pulses or waves;

or a combination of ultrasound pulses or waves, electromagnetic pulses or waves, and induced ultrasound pulses or waves.

17. The system of claim 12, wherein the ultrasound pulses or waves have a frequency between about 20 kHz and about 10 Gigahertz.

18. The system of claim 17, wherein the ultrasound pulses or waves comprises two frequencies or multiple frequencies.

19. The system of claim 17, wherein the ultrasound pulses or waves comprise broad-band ultrasound pulses or waves generated by the ultrasound transducer.

20. The system of claim 17, further comprising:

an electromagnetic source comprising a pulsed laser light source that generates short optical pulses or waves;

an electromagnetic delivery subsystem comprising at least one lens that delivers the short optical pulses or waves to the target tissue, where the optical pulses or waves generate thermoelastic ultrasound pulses or waves in the target tissue, and

a thermoelastic ultrasound detection subsystem comprising an ultrasound transducer that detects reflected, refracted, scattered, back-scattered, or forward-scattered thermoelastic ultrasound pulses or waves,

where the electronic subsystem is further;

(1) records and processes the detected thermoelastic ultrasound pulses or waves to determine (a) at least one thermoelastic ultrasound time of flight evidencing the boundaries or interfaces within the target tissue from the detected thermoelastic ultrasound pulses or waves, and/or (b) at least one thermoelastic ultrasound dimension of the target tissue from the detected thermoelastic ultrasound pulses or waves, and

(2) improves the calculation of the glucose concentration value using (1) the at least one thermoelastic ultrasound time of flight, and/or (2) the at least one thermoelastic ultrasound dimension.

21. The system of claim 12, wherein the ultrasound detection subsystem is further configured to detect attenuation, phase, and frequency spectrum of the ultrasound pulses or waves reflected from the target tissue to improve an accuracy and specificity of the glucose concentration value.

22. The system of claim 12, wherein the target tissue comprises a skin tissue, an eye tissue, a mucosal tissue, a nail bed, a lunula, a connective tissue, a muscle tissue, a blood vessel, a cartilage tissue, or a tendon tissue.

23. The system of claim 22, wherein the skin tissue includes a dermis, an epidermis, or subcutaneous fat and the eye tissue includes a lens, an anterior chamber, a vitreous cavity, an eye ball, or a sclera.